7JX3
Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 4.2.2 |
| Synchrotron site | ALS |
| Beamline | 4.2.2 |
| Temperature [K] | 100 |
| Detector technology | CMOS |
| Collection date | 2020-08-07 |
| Detector | RDI CMOS_8M |
| Wavelength(s) | 0.97625 |
| Spacegroup name | C 1 2 1 |
| Unit cell lengths | 79.540, 127.780, 192.280 |
| Unit cell angles | 90.00, 96.66, 90.00 |
Refinement procedure
| Resolution | 47.500 - 2.650 |
| R-factor | 0.2591 |
| Rwork | 0.258 |
| R-free | 0.28810 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6m0j |
| RMSD bond length | 0.004 |
| RMSD bond angle | 1.398 |
| Data reduction software | XDS |
| Data scaling software | Aimless |
| Phasing software | PHASER (2.8.3) |
| Refinement software | REFMAC (5.8.0258) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 47.750 | 47.750 | 2.730 |
| High resolution limit [Å] | 2.650 | 11.240 | 2.650 |
| Rmerge | 0.199 | 0.044 | 2.418 |
| Rmeas | 0.215 | 0.047 | 2.619 |
| Rpim | 0.079 | 0.018 | 0.999 |
| Total number of observations | 406155 | 4953 | 30682 |
| Number of reflections | 55237 | 714 | 4503 |
| <I/σ(I)> | 8.7 | 37.6 | 0.7 |
| Completeness [%] | 99.6 | 93.4 | 99.9 |
| Redundancy | 7.4 | 6.9 | 6.8 |
| CC(1/2) | 0.996 | 0.997 | 0.390 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 295 | 16.2% w/v PEG4000, 0.09 M sodium citrate, pH 6.0, 0.18 M ammonium acetate, 0.02 M potassium acetate, 0.01 MES, pH 6, 1.5% v/v pentaerythritol ethoxylate (15/4 EO/OH) |






